Effects of the melatonin on the kidney of high fat diet fed obese rats: A stereological and histological approach

Ondokuz Mayis Universitesi Tip Dergisi

Volumn 30, Issue 2, 2013, Pages 153-158

  Yurt, Kiymet Kübra ^a   Kayhan, Elif ^a   Zuhal Altunkaynak, B ^a   Tümentemur, Gamze ^a   Kaplan, Süleyman ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Glomerulus; Kidney; Melatonin; Obesity; Physical disector; Stereology

Indexed keywords

EID: 84886303549     PISSN: 13002996     EISSN: None     Source Type: Journal    
DOI: 10.5835/jecm.omu.30.02.013     Document Type: Review

References (47)

1. Altunkaynak, B. Z., 2005. Effects of high fat diet induced obesity on female rat livers (a histochemical study). Eur. J. Gen. Med. 2, 100-109.
2. Altunkaynak, B. Z., Özbek, E., 2006. Obezite: Nedenleri ve tedavi seçenekleri. Van Tip Dergisi. 13, 138-142.
3. Altunkaynak M. E., Özbek, E., Altunkaynak, B. Z., Can, I., Unal, D., Unal, B., 2008. The effects of high-fat diet on the renal structure and morphometric parametric of kidneys in rats. J Anat. 6, 845-852.
4. Aguila, M. B., Mandarim-De-Lacerda, C. A., 2003. Effects of chronic high fat diets on renal function and cortical structure in rats. Exp. Toxicol Pathol. 55, 187-195.
5. Arangino, S., Cagnacci, A., Angiolucci, M., Vacca, A. M., Longu, G., Volpe, A., Melis, G. B., 1999. Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am. J. Cardiol. 83, 1417-1419.
6. Armitage, J. A., Lakasing, L., Taylor, P. D., Balachandran, A. A., Jensen, R. I., Dekou, V., Ashton, N., Nyengaard, J. R., Poston, L., 2005. Developmental programming of aortic and renal structure in offspring of rats fed fat-rich diets in pregnancy. J. Physiol. 565, 171-184.
7. Bosma, R. J., van der Heide, J. J., Oosterop, E. J., de Jong, P. E., Navis, G., 2004. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int. 65, 259-265.
8. Bosma, R. J., Krikken, J. A., Homan, J. J., van der Heide, de Jong, P. E., Navis, G., 2006. Obesity and renal hemodynamics. Contrib. Nephrol. 151, pp. 184-202.
9. Burgess, H. J., Sletten, T., Savic, N., Gilbert, S. S., Dawson, D., 2001. Effects of bright light and melatonin on sleep propensity temperature and cardiac activity at night. J. Appl. Physiol. 91, 1214-1222.
10. Cavallo, A., Daniels, S. R., Dolan, L. M., Bean, J. A., Khoury, J. C., 2004a. Blood pressure-lowering effect of melatonin in type 1 diabetes. J. Pineal Res. 36, 262-266.
11. Cavallo, A., Daniels, S. R., Dolan, L. M., Khoury, J. C., Bean, J. A., 2004b. Blood pressure response to melatonin in type 1 diabetes. Pediatr. Diabetes. 5, 26-31.
12. Chen, J., Muntner, P., Hamm, L. L., Jones, D. W., Batuman, V., Fonseca, V., Whelton, P. K., He, J., 2004. The metabolic syndrome and chronic kidney disease in U. S. adults. Ann. Intern. Med. 140, 167-174.
13. Ding, C. N., Cao, Y. X., Zhou, L., Zhu, D. N., Shen, Z. Y., Fei, M. Y., Yu, P., 2001. Effects of microinjection of melatonin and its receptor antagonists into anterior hypothalamic area on blood pressure and heart rate in rats. Acta Pharmacol. Sin. 22, 997-1002.
14. Drew, J. E., Williams, L. M., Hannalý, L. T., Barrett, P., Abramovich, D. R., 1998. Melatonin receptors in the human fetal kidney: 2-[1 125] iodomelatonin binding sites cornelated with expression of Mel 1a and Mel 1b receptor genes. J. Endocrinol. 156, 261-267.
15. Gilat, T., Leikin-Frenkel, A., Goldiner, I., Juhel, C., Lafont, H., Gobbi, D., Konikoff, F. M., 2003. Prevention of diet-induced fatty liver in experimental animals by the oral administration of a fatty acid bile acid conjugate (FABAC). Hepatology; 38, 436-442.
16. Girouard, H., Chulak, C., Kejossec, M., Lamontahne, D., Champlain, Y., 2002. Vasorelexant effects of the chronic treatment with melatonin on mesenteric artery and aorta of spontaneously hypertansive rats. J. Hypertens. 19, 1369-1377.
17. Griffin, K. A., Kramer, H., Bidani, A. K., 2008. Adverse renal consequences of obesity. Am. J. Physiol Renal Physiol. 294, 685-696.
18. Gundersen, H. J. G., Jensen, E. B., 1987. The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 147, 229-263.
19. Hall, J. E., Kuo, J. J., da Silva, A. A., de Paula, R. B., Liu, J., Tallam, L., 2003a. Obesity-associated hypertension and kidney disease. Curr. Opin Nephrol. Hypertens. 195-200.
20. Hall, J. E., Jones, D. W., Kuo, J. J., da Silva, A., Tallam, L. S., Liu, J., 2003b. Impact of the obesity epidemic on hypertension and renal disease. Curr Hypertens Rep. 386-392.
21. Hall, J. E., 1994. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension. 23, 381-394.
22. Handa, K., Kreiger, N., 2002. Diet patterns and the risk of renal cell carcinoma. Public Health Nutr. 5, 757-767.
23. Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M. R., Groop, L., 2001. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 24, 683-689.
24. Jiang, T., Wang, Z., Proctor, G., Proctor, G., Moskowitz, S., Liebman, S. E., Rogers, T., Lucia, M. S., Li, J., Levi, M., 2005. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1cdependent pathway. J. Biol. Chem. 280, 32317-32325.
25. Kaplan, S., Gokyar, A., Unal, B., Tunç, A. T., Bahadir, A., Aslan, H., 2005. A simple technique for localizing consecutive fields for disector pairs in light microscopy: Application to neuron counting in rabbit spinal cord following spinal cord injury. J. Neurosci Methods. 145, 277-284.
26. Karppanen, H., Vapaatalo, H., Lahovaara, S., Paasonen, M. K., 1970. Studies with pinealectomized rats. Pharmacology. 3, 76-84.
27. Kasiske B. L., Napier J., 1985. Glomerular sclerosis in patients with massive obesity. Am J Nephrol. 5, 45-50.
28. Kramer, H. J., Saranathan, A., Luke, A., et al. 2006. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol. 17, 1453-1459.
29. Kramer, H., Luke, A., Obesity and kidney disease: A big dilemma. 2007. Curr. Opin. Nephrol. Hypertens. 16, 237-241.
30. Laflamme, A. K., WU, L., Faucart, S., Champlain, Y., 1998. Impaired basal sympathetic tone and alfa1 adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am. J. Hypertens. 11, 219-222.
31. Lakka, H. M., Laaksonen, D. E., Lakka, T. A., Niskanen, L. K., Kumpusalo, E., Tuomilehto, J., Salonen, J. T., 2002. The metabolic syndrome and total and cardiovascular disease mortality in middLle-aged men. J. Am. Med. Assoc. 288, 2709-2716.
32. Nowak, Y. Z., Zawilsha, Y. B., 1998. Melatonin and its physiological and therapeutic properties. Pharm. World. Sci. 20, 18-27.
33. Nicol, C. J., Adachi, M., Akiyama, T. E., Gonzalez, F. J., 2005. PPARgamma in endothelial cells influences high fat diet-induced hypertension. Am. J. Hypertens. 18:549-56.
34. Praga, M., Hernandez, E., Andres, A., Leon, M., Ruilope, M. L., Rodicio L. J., 1995. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron. 70, 35-41.
35. Praga, M., Hernández, E., Morales, E., et al., 2001. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 16, 1790-1798.
36. Prunet-Marcassus, B., Desbazeille, M., Bros, A., Louche, K., Delagrange, P., Renard, P., et al., 2003. Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology. 144, 5347-5352.
37. Quiroz, Y., Ferrebuz, A., Romero, F., Vaziri, N. D., Rodriguez-Iturbe, B., 2008. Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction. Am. J. Physiol Renal Physiol. 294, 336-344.
38. Rasmussen, D. D., Boldt, B. M., Wilkinson, C. W., Yellon, S. M., Matsumoto, A. M., 1999. Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology. 140, 1009-1012.
39. Sahin, B., Emirzeoglu, M., Uzun, A., Incesu, L., Bek, Y., Bilgic, S., Kaplan, S., 2003. Unbiased estimation of the liver volume by the Cavalieri principle using magnetic resonance images. Eur. J. Radiol. 47:164-170.
40. Scheer, F. A., Van Montfrans, G. A., et al. 2004. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension. 43, 192-197.
41. Shoham, D. A., Vupputuri, S., Kshirsagar, A. V., 2005. Chronic kidney disease and life course socioeconomic status: A review. Adv. Chronic Kidney Dis. 12, 56-63.
42. Song, Y., Poon, A. M. S., Lee, P. P. N., Pamg, S. F., 1993. Putative melatonin receptors in the male guinea pig kidney. J. Pineal Res. 15, 153-160.
43. Sterio, D. C., 1984. The unbiased estimation of number and sizes of arbitrary particles using the disector. J. Microsc. 134, 127-136.
44. Unal, B., Özbek, M. E., Aydin, M. D., et al., 2004. Effect of haloperidol on the numerical density of neurons and nuclear height in the rat hippocampus: a stereological and histopathological study. Neurosci Res. Commun. 34, 1-9.
45. Usardi, P., Preti, P., et al., 1997. Effect of bed time melatonin ingestion on blood pressure of normotensive subjects. Blood. Press. Monit. 2, 99-103.
46. Yilmaz, A., Suleyman, H., Umudum, Z., Sahin, Y. N., 2002. The effect of adrenalectomy on leptin levels and some metabolic parameters in rats with diet-induced obesity. Biol. Pharm. Bull. 25, 580-583.
47. Zanoboni, A., Zanoboni-Muciaccia, W., 1967. Experimental hypertension in pinealectomized rats. Life Sci. 6, 2327-2331.